Follow
Mohammad Mashreghi
Mohammad Mashreghi
PhD in Pharmaceutical Nanotechnology, Mashhad University of Medical Sciences
Verified email at mums.ac.ir
Title
Cited by
Cited by
Year
Biosynthesis of selenium nanoparticles using Enterococcus faecalis and evaluation of their antibacterial activities
S Shoeibi, M Mashreghi
Journal of Trace Elements in Medicine and Biology 39, 135-139, 2017
1862017
Angiogenesis biomarkers and their targeting ligands as potential targets for tumor angiogenesis
M Mashreghi, H Azarpara, MR Bazaz, A Jafari, A Masoudifar, H Mirzaei, ...
Journal of cellular physiology 233 (4), 2949-2965, 2018
1292018
Silver-zinc oxide nanocomposite: From synthesis to antimicrobial and anticancer properties
SM Mousavi-Kouhi, A Beyk-Khormizi, MS Amiri, M Mashreghi, MET Yazdi
Ceramics International 47 (15), 21490-21497, 2021
862021
Development of chitosan-coated liposome for pulmonary delivery of N-acetylcysteine
H Hamedinasab, AH Rezayan, M Mellat, M Mashreghi, MR Jaafari
International journal of biological macromolecules 156, 1455-1463, 2020
812020
A study on the role of cholesterol and phosphatidylcholine in various features of liposomal doxorubicin: From liposomal preparation to therapy
H Farzaneh, ME Nik, M Mashreghi, Z Saberi, MR Jaafari, M Teymouri
International journal of pharmaceutics 551 (1-2), 300-308, 2018
772018
Redox-sensitive nanoscale drug delivery systems for cancer treatment
E Mirhadi, M Mashreghi, MF Maleki, SH Alavizadeh, L Arabi, A Badiee, ...
International journal of pharmaceutics 589, 119882, 2020
762020
Green Synthesis of Silver Nanoparticles Using Helichrysum graveolens for Biomedical Applications and Wastewater Treatment
ME Taghavizadeh Yazdi, MS Amiri, S Akbari, M Sharifalhoseini, ...
BioNanoScience 10, 1121-1127, 2020
622020
Anti-Epcam aptamer (Syl3c)-functionalized liposome for targeted delivery of doxorubicin: In vitro and in vivo antitumor studies in mice bearing C26 colon carcinoma
M Mashreghi, P Zamani, SA Moosavian, MR Jaafari
Nanoscale Research Letters 15, 1-13, 2020
572020
Preparation and characterization of stable nanoliposomal formulations of curcumin with high loading efficacy: in vitro and in vivo anti-tumor study
M Karimi, F Gheybi, P Zamani, M Mashreghi, S Golmohammadzadeh, ...
International journal of pharmaceutics 580, 119211, 2020
512020
Antimycobacterial, Anticancer, Antioxidant and Photocatalytic Activity of Biosynthesized Silver Nanoparticles Using Berberis Integerrima
ME Taghavizadeh Yazdi, M Darroudi, MS Amiri, H Zarrinfar, HA Hosseini, ...
Iranian Journal of Science and Technology, Transactions A: Science, 1-11, 2022
502022
Folate targeted PEGylated liposomes for the oral delivery of insulin: In vitro and in vivo studies
JR Yazdi, M Tafaghodi, K Sadri, M Mashreghi, AR Nikpoor, ...
Colloids and Surfaces B: Biointerfaces 194, 111203, 2020
482020
Ultrasound-based synthesis of ZnO·Ag2O3 nanocomposite: characterization and evaluation of its antimicrobial and anticancer properties
ME Taghavizadeh Yazdi, F Nourbakhsh, M Mashreghi, SH Mousavi
Research on Chemical Intermediates 47, 1285-1296, 2021
472021
Biological synthesis and characterization of gold nanoparticles using Verbascum speciosum Schrad. and cytotoxicity properties toward HepG2 cancer cell line
SM Mousavi-Kouhi, A Beyk-Khormizi, V Mohammadzadeh, M Ashna, ...
Research on Chemical Intermediates, 1-12, 2022
442022
Anticancer, antimicrobial, and dye degradation activity of biosynthesised silver nanoparticle using Artemisia kopetdaghensis
ME Taghavizadeh Yazdi, M Darroudi, MS Amiri, HA Hosseini, ...
Micro & Nano Letters 15 (14), 1046-1050, 2020
432020
Topical effects of frog “Rana ridibunda” skin secretions on wound healing and reduction of wound microbial load
M Mashreghi, MR Bazaz, NM Shahri, A Asoodeh, M Mashreghi, ...
Journal of ethnopharmacology 145 (3), 793-797, 2013
392013
Resveratrol-mediated gold-nanoceria synthesis as green nanomedicine for phytotherapy of hepatocellular carcinoma
G Adel, M Javad, MS Amiri, M Mohammad, H Alireza, H Aliakbar, ...
Frontiers in Bioscience 27 (8), 1-6, 2022
372022
Endogenous stimuli-responsive linkers in nanoliposomal systems for cancer drug targeting
MF Maleki, A Jafari, E Mirhadi, A Askarizadeh, B Golichenari, ...
International journal of pharmaceutics 572, 118716, 2019
332019
Combination therapy with liposomal doxorubicin and liposomal vaccine containing E75, an HER-2/neu-derived peptide, reduces myeloid-derived suppressor cells and improved tumor …
P Zamani, JG Navashenaq, M Teymouri, M Karimi, M Mashreghi, ...
Life sciences 252, 117646, 2020
322020
Preparation and characterization of nanoliposomal bortezomib formulations and evaluation of their anti-cancer efficacy in mice bearing C26 colon carcinoma and B16F0 melanoma
M Korani, S Ghaffari, H Attar, M Mashreghi, MR Jaafari
Nanomedicine: nanotechnology, biology and medicine 20, 102013, 2019
302019
Improving anti-tumour efficacy of PEGylated liposomal doxorubicin by dual targeting of tumour cells and tumour endothelial cells using anti-p32 CGKRK peptide
M Mashreghi, M Faal Maleki, M Karimi, F Kalalinia, A Badiee, MR Jaafari
Journal of drug targeting 29 (6), 617-630, 2021
282021
The system can't perform the operation now. Try again later.
Articles 1–20